ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,584.54
-0.88%
US Tech 100
19,681.20
-2.17%
Dow Jones
39,753.75
0.08%
Brent Oil
85.345
0.28%
Bitcoin
57,299.87
-0.09%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. ADC Therapeutics SA (ADCT) Quote

ADC Therapeutics SA

ADC Therapeutics SA (ADCT)

NYSE
3.79
0.64
(20.32%)
Closed July 11 4:00PM
Delayed by 15 minutes
3.62
-0.17
(-4.49%)
After Hours: 7:00PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.62
Bid
-
Ask
-
Volume
913,945
3.23 Day's Range 3.88
0.359908 52 Week Range 6.04
Market Cap
260.864M
Previous Close
3.15
Open
3.23
Last Trade
8
@
3.8
Last Trade Time
Financial Volume
$ 3,311,778
VWAP
3.6236
Average Volume (3m)
800,869
Shares Outstanding
82,814,000
Dividend Yield
-
PE Ratio
-1.33
Earnings Per Share (EPS)
-2.83
Revenue
69.56M
Net Profit
-234.53M

About ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602,... ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. Show more

Sector
Drugs And Proprietary-whsl
Industry
Drugs And Proprietary-whsl
Website
www.adctherapeutics.com
Headquarters
Lausanne, Che
Founded
1970
ADC Therapeutics SA is listed in the Drugs And Proprietary-whsl sector of the New York Stock Exchange with ticker ADCT. The last closing price for ADC Therapeutics was $3.15. Over the last year, ADC Therapeutics shares have traded in a share price range of $ 0.359908 to $ 6.04.

ADC Therapeutics currently has 82,814,000 shares outstanding. The market capitalization of ADC Therapeutics is $260.86 million. ADC Therapeutics has a price to earnings ratio (PE ratio) of -1.33.

ADCT Latest News

More News

Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital, Cancer Research Horizons and Lilly participated...

July 08 2024
GlobeNewswire Inc.

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

LAUSANNE, Switzerland, July 01, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company has made grants of options to purchase an aggregate of 172,400 of the...

July 01 2024
GlobeNewswire Inc.

ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

LAUSANNE, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company is set to join the Russell 2000® Index and the broad-market Russell...

June 27 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

June 18 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 18 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 18 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 14 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.4514.19558359623.173.883.015174233.15958693CS
40.4815.28662420383.143.882.450511504463.09420672CS
12-1.33-26.86868686874.955.172.45058008693.56211358CS
261.4264.54545454552.26.041.717669603.79644633CS
521.6785.6410256411.956.040.3599086534962.76400877CS
156-20.74-85.139573070624.36320.3599084606355.44394804CS
260-26.38-87.93333333333056.58990.35990840639910.13891752CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LCFYLocafy Ltd
$ 6.10
(162.92%)
46.08M
KZIAKazia Therapeutics Ltd
$ 1.24
(85.57%)
215.06M
CYNCYNGN Inc
$ 7.20
(81.82%)
17.89M
NEXINexImmune Inc
$ 3.84
(66.23%)
34.48M
BDRXBiodexa Pharmaceuticals PLC
$ 1.08
(51.88%)
59.99M
CETUUCetus Capital Acquisition Corporation
$ 7.00
(-29.72%)
1.42k
TRIBTrinity Biotech PLC
$ 2.046
(-28.96%)
81.02k
CINGCingulate Inc
$ 0.4845
(-25.23%)
1.33M
IVPInspire Veterinary Partners Inc
$ 5.5842
(-24.54%)
2.35M
SLRXSalarius Pharmaceuticals Inc
$ 2.12
(-22.70%)
1.99M
NVDANVIDIA Corporation
$ 127.40
(-5.57%)
362.02M
MAXNMaxeon Solar Technologies Ltd
$ 0.24
(13.85%)
349.82M
TSLATesla Inc
$ 241.03
(-8.44%)
217.69M
KZIAKazia Therapeutics Ltd
$ 1.24
(85.57%)
215.06M
SQQQProShares UltraPro Short QQQ
$ 7.63
(6.42%)
178.49M

ADCT Discussion

View Posts
PonkenPlonken PonkenPlonken 2 weeks ago
Somethings very right here. Looking for 5+
👍️0
glenn1919 glenn1919 2 weeks ago
ADCT......................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
ADCT...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
ADCT MASSIVE BREAK OUT HERE
👍️0
glenn1919 glenn1919 5 months ago
ADCT..................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 5 months ago
ADCT new 52 week high
👍️0
Monksdream Monksdream 5 months ago
ADCT new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
Brilliantly played to 4.80. Precision technical charting.
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
ADCT...TARGET COMING IN
👍️0
glenn1919 glenn1919 5 months ago
ADCT......................................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
ADCT monster
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
ADCT...4.82 NEXT
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
ADCT..WAITED TOO LOG TO ENTER THIS BEAST!!!!
👍️0
glenn1919 glenn1919 5 months ago
ADCT.......................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 months ago
ADCT.................................................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 months ago
ADCT.........................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 months ago
ADCT...........................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 months ago
ADCT......................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
ADCT.........................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
ADCT.....................................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 months ago
ADCT new 52 week low
👍️0
glenn1919 glenn1919 9 months ago
ADCT.......................https://stockcharts.com/h-sc/ui?s=ADCT&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 months ago
ADCT new 52 week low
👍️0
Monksdream Monksdream 10 months ago
ADCT new 52 week low
👍️0
Monksdream Monksdream 10 months ago
ADCT new 52 week low
👍️0
Monksdream Monksdream 10 months ago
ADCT new 52 week low
👍️0
Monksdream Monksdream 10 months ago
ADCT new 52 week low
👍️0
Monksdream Monksdream 10 months ago
ADCT new 52 week low

👍️0
Monksdream Monksdream 12 months ago
ADTC new 52 week low
👍️0
tw0122 tw0122 1 year ago
ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL
👍️0
81vette 81vette 1 year ago
Ripe for merger/buyout/Big Bang boom
👍️0
81vette 81vette 1 year ago
Revenue increased yoy,profits increase yoy,tons of cash on hand,the more I dig the more I confident I am, (usually more digging,less liking)
👍️0
81vette 81vette 1 year ago
$3.3m print and $760k omg,FOLLOW THE $ is the saying
👍️0
81vette 81vette 1 year ago
Great company,I loaded 2tons today lots of institutional buying and insiders have lots of skin in it,28 patents pending for awhile,many should be getting approved soon.macd crossed to bulls on March 27th,I am following the $,3 times it crossed in last year period,every time a run continued for many days,low risk high reward babe
👍️ 1
conix conix 2 years ago
ADCT in Seeking Alpha

https://seekingalpha.com/article/4561171-adc-therapeutics-running-through-bad-luck?
👍️0
north40000 north40000 2 years ago
https://ih.advfn.com/stock-market/NYSE/adc-therapeutics-ADCT/stock-news/87749724/adc-therapeutics-obtient-un-code-j-permanent-pour
👍️0
ibelurkin ibelurkin 3 years ago
FDA approves ADC's biologic Zynlonta for B-cell lymphom

👍️0
stockguard stockguard 3 years ago
ADC Therapeutics SA
Cowen healthcare conference: March 4th, 2021

https://wsw.com/webcast/cowen81/adct/1925484
👍️0
~WAVE~ ~WAVE~ 14 years ago
Great News! A Buyout!
The Stock Compound Called It!
👍️0
~WAVE~ ~WAVE~ 14 years ago
ADCT got called this morning on The Stock Compound's scan.
stockcompound.blogspot.com/

That pays for my membership fee!
👍️0
zomniac zomniac 14 years ago
Whoaaa
What's happening ???
👍️0
mlkrborn mlkrborn 14 years ago
DC Telecommunications (ADCT Quote) rallied by 80 cents, or 14.9%, to $6.18 after the broadband communications provider said late Monday it had a fiscal first-quarter profit of 2 cents, better than analysts' expectations that ADC would break even in the quarter. ADC also offered in-line earnings and revenue guidance for its fiscal second quarter. Volume topped 5.71 million shares, compared to the 50-day average daily volume of 2.07 million, according to the Nasdaq.
👍️0
OldAIMGuy OldAIMGuy 17 years ago
Nice uptick in ADCT today. Earnings and sales are up on the most recent report.

Best regards, Tom
👍️0
OldAIMGuy OldAIMGuy 17 years ago
This is the first post here in over a year. Well, the news is good, so that warrants posting.

http://biz.yahoo.com/bizj/070129/1409983.html?.v=1

ADCT's efforts of a few years ago are providing a bit of a windfall for them now.

The company has earnings again and a P/E that's not in nosebleed territory right now. In the lower half of its 52 week range, it should have some reasonable support going forward.



The cyclical nature of the Telecomm industry makes this a trade-able stock for ST traders as well as longer term AIM users.

Best regards, Tom
👍️0
OldAIMGuy OldAIMGuy 19 years ago
A reasonable level of "insider" selling going on early this month. I assume it was officers exercising options. The exercise price was $17.49.

We better watch this one closely for a while.

Best regards, Tom
👍️0
ljk ljk 20 years ago
Hi, Tom.

Good to hear from you!

Unfortunately I had to let my ADCT go, but I've noticed the recent action and I was thinking that when I can I should take another position.

I have had considerable AIM action in STEM this week and also the week before last, in SELLS. I sold at 1.98, and 2.10 last week or the week before, and then yesterday 2.32, 2.55, and then I bumped up from 0% to 4% on the SELL and had a sell this morning at 2.95. No news to fuel the move yesterday and today!

I also had some AIM action on BIOM a month or two ago.

Overall, not doing that well, but as usual, the AIM stocks are usually the best producers. :)

Best regards,
Linda
👍️0
OldAIMGuy OldAIMGuy 20 years ago
Hi Linda, Are you still involved with ADCT in any way? I'm still holding shares. Haven't had an opportunity to trade any recently, however.

I like the price and volume action recently, however. It's risen nicely after bottoming at under $2 a few weeks ago.

Best regards, Tom
👍️0
OldAIMGuy OldAIMGuy 21 years ago
Hi Linda, I agree. It was such a nice day going earlier, where'd all the buyers go?

tv
👍️0
ljk ljk 21 years ago
Interesting. I only seem to have the option of making teeny tiny charts on stockcharts right now. Must be doing something wrong. Do you pay them money?

Too bad everything's being beaten into the ground this afternoon, but the silver lining is that AIM made me buy two more batches of TXCC. A sea of blood on my screen, though...

Linda
👍️0
OldAIMGuy OldAIMGuy 21 years ago
Hi Linda, Interesting to compare IYZ (telecom index fund) to ADCT for the year to date:
http://stockcharts.com/webcgi/perf.html?IYZ,adct
(you'll have to use the bar at the bottom to stretch the time line to the beginning of the year.

ADCT's been quite a bit more volatile than the index fund. Maybe I'll have to see if I can stimulate my AIM account to start participating somehow.

Best regards, Tom
👍️0

Your Recent History

NYSE
ADCT
ADC Therapeutics
USOTC
NTCI
NuTech (GM)
KOSDAQ
127120
DNA Link
BIT
UC2XVU
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved